TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15890735

Group type: EXPERIMENTAL
Intervention: Delayed hCG administration (late-hCG group, n = 5)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Early hCG administration (early-hCG group, n = 5)
Number of subjects: 10
Study: 12235246

Group type: EXPERIMENTAL
Intervention: 5 mg of oral folic acid for 6 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (subjects with below-median tHcy reduction)
Number of subjects: 27
Study: 9440742

Group type: EXPERIMENTAL
Intervention: Docetaxel monotherapy
Number of subjects: 936
Study: 7674104

Group type: EXPERIMENTAL
Intervention: ST waveform + CTG
Number of subjects: 2400

Group type: COMPARATOR
Intervention: CTG only
Number of subjects: 2400
Study: 3289398

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel (2.5 mg)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 29884144

Group type: EXPERIMENTAL
Intervention: Specific computerized training (ST)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nonspecific computerized training (nST)
Number of subjects: 36
Study: 25942419

Group type: EXPERIMENTAL
Intervention: Functional Inertial Eccentric Overload and Vibration Training (EVT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional combined training (CONV)
Number of subjects: 24
Study: 25682273

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Opioids
Number of subjects: 65
Study: 23263970

Group type: EXPERIMENTAL
Intervention: Lingual 24% sucrose (1 ml) administered 2 min before OGT insertion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water (1 ml) administered 2 min before OGT insertion (Placebo)
Number of subjects: 60
Study: 20797477

Group type: EXPERIMENTAL
Intervention: Fermented red pepper paste (FRPP)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 18298562

Group type: EXPERIMENTAL
Intervention: PET
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: PET/CT
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: PET and/or PET/CT
Number of subjects: 88
Study: 15925045

Group type: EXPERIMENTAL
Intervention: Vaginal administration of 50 microg misoprostol (n=100)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Oxytocin induction (n=100)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Transcervical insertion of a Foley balloon (n=100)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Spontaneous follow-up (n=300)
Number of subjects: 600
Study: 14586050

Group type: EXPERIMENTAL
Intervention: Asthma nurse follow-up
Number of subjects: 74

Group type: COMPARATOR
Intervention: Paediatrician follow-up
Number of subjects: 74
Study: 9862846

Group type: EXPERIMENTAL
Intervention: trapidil (400 mg/d) and ticlopidine (250 mg/d)
Number of subjects: 90

Group type: COMPARATOR
Intervention: heparin treatment (12 to 24 U/kg bolus, 1 week intravenous, 4 weeks subcutaneous)
Number of subjects: 90
Study: 9295485

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 51

Group type: COMPARATOR
Intervention: Preoperative instruction only (Control)
Number of subjects: 51
Study: 2070507

Group type: EXPERIMENTAL
Intervention: Completion of the second questionnaire after the 8-month assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Completion of the second questionnaire before the assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health visitor assessment at 8 months
Number of subjects: 0
Study: 6840954

Group type: EXPERIMENTAL
Intervention: Serum-cholesterol-lowering (SCL) diet, low in saturated fats and cholesterol, high in poly-unsaturated fats
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal hospital diet
Number of subjects: 0
Study: 31792259

Group type: EXPERIMENTAL
Intervention: 10,000 Lux light box
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 2,000 Lux LED blue‐enriched glasses
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (ambient dim-light at 8 lux)
Number of subjects: 18
Study: 29261824

Group type: EXPERIMENTAL
Intervention: Varenicline tartrate, 1mg twice daily for 16 weeks
Number of subjects: 131
Study: 26875901

Group type: EXPERIMENTAL
Intervention: Off-pump coronary bypass grafting by small incision at the left chest
Number of subjects: 201

Group type: COMPARATOR
Intervention: Coronary bypass grafting by extracorporeal circulation
Number of subjects: 201
Study: 25377361

Group type: EXPERIMENTAL
Intervention: Epley maneuver
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Semont maneuver
Number of subjects: 99

Group type: COMPARATOR
Intervention: Sham maneuver
Number of subjects: 99
Study: 22549506

Group type: EXPERIMENTAL
Intervention: Advanced Pneumatic Compression Device (APCD) - Flexitouch system, HCPCS E0652
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard Pneumatic Compression Device (SPCD) - Bio Compression 2004, HCPCS E0651
Number of subjects: 36
Study: 19230767

Group type: EXPERIMENTAL
Intervention: Low GI meal (1 g kg(‐1) body mass of carbohydrate, consumed 45 min prior to TT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low GI meal
Number of subjects: 10

Group type: COMPARATOR
Intervention: High GI meal
Number of subjects: 10
Study: 17244135

Group type: EXPERIMENTAL
Intervention: Pyramid-based education with a full-time nurse educator for care-aides
Number of subjects: 14

Group type: COMPARATOR
Intervention: Seminar with a dental hygienist for care-aides (control group)
Number of subjects: 14
Study: 15124260

Group type: EXPERIMENTAL
Intervention: Depressed mood at baseline
Number of subjects: 57
Study: 11584093

Group type: EXPERIMENTAL
Intervention: Iodized oil supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsupplemented group (placebo)
Number of subjects: 0
Study: 9428853

Group type: EXPERIMENTAL
Intervention: Fentanyl Oralet (10-15 micrograms/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (candy matrix)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (i.v. fentanyl 2 micrograms/kg)
Number of subjects: 40
Study: 7719946

Group type: EXPERIMENTAL
Intervention: Various pharmacologic agents used in the treatment of CHF, specific dosages and durations not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapies for CHF, specific agents not mentioned.
Number of subjects: 0
Study: 2540005

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 30

Group type: COMPARATOR
Intervention: ACTH
Number of subjects: 30

Group type: COMPARATOR
Intervention: Methylprednisolone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CSF and neurophysiological parameters)
Number of subjects: 30
Study: 1007937

Group type: EXPERIMENTAL
Intervention: Unilateral, non-dominant ECT with four treatments weekly
Number of subjects: 103

Group type: COMPARATOR
Intervention: Unilateral, non-dominant ECT with two treatments weekly
Number of subjects: 103
Study: 30004111

Group type: EXPERIMENTAL
Intervention: DEFA5 rs4415345 G vs. C
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: DEFA5 rs4610776 T vs. A
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: REG3A SNP
Number of subjects: 443
Study: 26936722

Group type: EXPERIMENTAL
Intervention: Phase aberration correction
Number of subjects: 4

Group type: COMPARATOR
Intervention: Uncorrected phase aberration
Number of subjects: 4
Study: 24715425

Group type: EXPERIMENTAL
Intervention: Liuwei Dihuang Granule (LDG) given for 3 menstrual cycles before IVF
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Liuwei Dihuang Granule (LDG)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo granule
Number of subjects: 66
Study: 23392652

Group type: EXPERIMENTAL
Intervention: Fake video or photograph of cheating shown after a 9‐min delay (Experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated false evidence over time (Experiment 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21155012

Group type: EXPERIMENTAL
Intervention: CPT‐11‐containing combination chemotherapy
Number of subjects: 657
Study: 18227526

Group type: EXPERIMENTAL
Intervention: Darbepoetin alpha (DA) 6.75 microg/kg every 4 weeks for up to 16 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Darbepoetin alpha (DA)
Number of subjects: 0
Study: 15099661

Group type: EXPERIMENTAL
Intervention: Risk reduction intervention focusing on safer injection and sex behaviors
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Motivational interviewing addressing lifestyle changes including drug treatment
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Free treatment (coupon for 90 days)
Number of subjects: 577

Group type: COMPARATOR
Intervention: Motivational interviewing
Number of subjects: 577
Study: 12369794

Group type: EXPERIMENTAL
Intervention: Genistein (54 mg/day)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hormone-replacement therapy (HRT; 1 mg of 17beta-estradiol combined with 0.5 mg of norethisterone acetate)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 10326110

Group type: EXPERIMENTAL
Intervention: Hookworm infection
Number of subjects: 729

Group type: EXPERIMENTAL
Intervention: Malaria parasitaemia
Number of subjects: 729

Group type: EXPERIMENTAL
Intervention: S. mansoni infection
Number of subjects: 729

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 729
Study: 7790678

Group type: EXPERIMENTAL
Intervention: Real ECT
Number of subjects: 0
Study: 2718973

Group type: EXPERIMENTAL
Intervention: Vasoconstricting nasal spray
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 25
Study: 776325

Group type: EXPERIMENTAL
Intervention: Plastic skin drapes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plastic wound drapes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no plastic drapes)
Number of subjects: 0
Study: 31773885

Group type: EXPERIMENTAL
Intervention: Geriatric Emergency Department Intervention (GEDI) model; nurse-led, physician-championed intervention; details on dosage and duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-GEDI, interim GEDI, and post-GEDI time periods; control group not explicitly defined but implies comparison across time periods.
Number of subjects: 0
Study: 31216533

Group type: EXPERIMENTAL
Intervention: Adapted Lifestyle‐integrated Functional Exercise (aLiFE) programme
Number of subjects: 31
Study: 28856843

Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire-9 items (online screening program)
Number of subjects: 230
Study: 25212229

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) - high dose
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) - medium dose
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) - low dose
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 22864620

Group type: EXPERIMENTAL
Intervention: 0.4% glyceryl trinitrate (GTN) ointment
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control (no GTN ointment)
Number of subjects: 203
Study: 21605381

Group type: EXPERIMENTAL
Intervention: On-line palliative care training program with tutorship using a Moodle Platform
Number of subjects: 169

Group type: COMPARATOR
Intervention: Traditional education
Number of subjects: 169
Study: 19451915

Group type: EXPERIMENTAL
Intervention: Risperidone 2-6 mg per day over 2-12 weeks
Number of subjects: 143
Study: 16882592

Group type: EXPERIMENTAL
Intervention: Balneotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 60
Study: 15605131

Group type: EXPERIMENTAL
Intervention: Nurse-administered massage and breathing techniques during latent phase of labour
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 40
Study: 11164149

Group type: EXPERIMENTAL
Intervention: PSA cutoff of 3.0 ng/mL or greater
Number of subjects: 8612

Group type: COMPARATOR
Intervention: PSA cutoff of 4.0 ng/mL or greater
Number of subjects: 8612

Group type: EXPERIMENTAL
Intervention: PSA range 3.0 to 3.9 ng/mL (new protocol)
Number of subjects: 8612

Group type: COMPARATOR
Intervention: PSA range 3.0 to 3.9 ng/mL (original protocol)
Number of subjects: 8612

Group type: EXPERIMENTAL
Intervention: PSA levels less than 2.9 ng/mL
Number of subjects: 8612
Study: 9227295

Group type: EXPERIMENTAL
Intervention: Oral aminophylline
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8188835

Group type: EXPERIMENTAL
Intervention: Manipulation and percutaneous Kirschner wiring with cast
Number of subjects: 23

Group type: COMPARATOR
Intervention: Manipulation and cast alone
Number of subjects: 23
Study: 3115843

Group type: EXPERIMENTAL
Intervention: Metformin (1.75 g for 15 days)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 24 hour fast
Number of subjects: 49
Study: 29108888

Group type: EXPERIMENTAL
Intervention: Multidomain intervention (nutritional guidance, exercise, cognitive training, and management of metabolic and vascular risk factors)
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Control group (general health advice)
Number of subjects: 1260

Group type: EXPERIMENTAL
Intervention: Multidomain intervention
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1260
Study: 27470060

Group type: EXPERIMENTAL
Intervention: Adjustable coaptive tape-based skin closure device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 40
Study: 24746000

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg three times a week for 12 months
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 92
Study: 23328428

Group type: EXPERIMENTAL
Intervention: Modified chitosan medical anti-adhesion membrane
Number of subjects: 86
Study: 20123873

Group type: EXPERIMENTAL
Intervention: Air abrasion followed by acid etching with 37 percent phosphoric acid
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser followed by acid etching with 37 percent phosphoric acid
Number of subjects: 45

Group type: COMPARATOR
Intervention: 37 percent phosphoric acid
Number of subjects: 45
Study: 18166408

Group type: EXPERIMENTAL
Intervention: Retreatment every 2 months (group A)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Retreatment every 3 months (group B)
Number of subjects: 203
Study: 15588043

Group type: EXPERIMENTAL
Intervention: Tiotropium (18-microg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salmeterol (50-microg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tiotropium + Salmeterol (18-microg + 50-microg)
Number of subjects: 20
Study: 11137723

Group type: EXPERIMENTAL
Intervention: Cold applied for 5 min before injection
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Cold applied for 5 min after injection
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Cold applied for 5 min pre and post injection
Number of subjects: 63

Group type: COMPARATOR
Intervention: No cold applied (control group)
Number of subjects: 63
Study: 9174866

Group type: EXPERIMENTAL
Intervention: Endoscopic stent insertion
Number of subjects: 201

Group type: COMPARATOR
Intervention: Surgical biliary bypass
Number of subjects: 201
Study: 7513876

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy guided by suppression of spontaneous arrhythmias
Number of subjects: 486

Group type: COMPARATOR
Intervention: Pharmacotherapy guided by suppression of stimulation‐inducible VT/VF
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 486

Group type: COMPARATOR
Intervention: Sodium channel blockers (imipramine, mexiletine, procainamide, propafenone, pirmenol, quinidine)
Number of subjects: 486
Study: 3117570

Group type: EXPERIMENTAL
Intervention: Serum lactic dehydrogenase (S-LDH) levels below 7.0 mukat 1(-1)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Serum lactic dehydrogenase (S-LDH) levels above 7.0 mukat 1(-1)
Number of subjects: 93
Study: 30768388

Group type: EXPERIMENTAL
Intervention: Incredible Years parenting intervention
Number of subjects: 387

Group type: COMPARATOR
Intervention: Control group (families with only child difficulties or less severe difficulties)
Number of subjects: 387
Study: 30415553

Group type: EXPERIMENTAL
Intervention: 5 mg/d folic acid supplements
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 27562972

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (rapid intravenous infusion of up to 2 L of cold saline)
Number of subjects: 1198

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1198
Study: 23132511

Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 21737482

Group type: EXPERIMENTAL
Intervention: Pain Assessment in Advanced Dementia scale (PAINAD)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Disability Distress Assessment Tool (DisDAT)
Number of subjects: 79
Study: 19552963

Group type: EXPERIMENTAL
Intervention: Paliperidone ER 3-12 mg/day
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 17328999

Group type: EXPERIMENTAL
Intervention: Placebo administration
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 5 mg nitrazepam
Number of subjects: 8

Group type: COMPARATOR
Intervention: Drug-free condition
Number of subjects: 8
Study: 15809948

Group type: EXPERIMENTAL
Intervention: Cryo/Cuff
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (EDA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 11498318

Group type: EXPERIMENTAL
Intervention: 10 mg ephedrine
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 15 mg ephedrine
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 20 mg ephedrine
Number of subjects: 108
Study: 8989009

Group type: EXPERIMENTAL
Intervention: Crystalloid prehydration (500 mL Hartmanns solution, n = 29)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Colloid prehydration (500 mL Haemaccel, n = 28)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No prehydration (n = 28)
Number of subjects: 85
Study: 8381228

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Permixon
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bazoton
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Various plant extracts (Talso, Strogen Forte, Prostagutt, Tadenan)
Number of subjects: 0
Study: 3623762

Group type: EXPERIMENTAL
Intervention: Systemic Cefuroxime
Number of subjects: 295

Group type: COMPARATOR
Intervention: Cefuroxime in bone cement
Number of subjects: 295
Study: 31705339

Group type: EXPERIMENTAL
Intervention: Probiotics (Gynophilus®) with metronidazole (500 mg twice a day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo with metronidazole (500 mg twice a day)
Number of subjects: 90
Study: 31004619

Group type: EXPERIMENTAL
Intervention: MaiStep delivered by psychologists (IG1)
Number of subjects: 1654

Group type: EXPERIMENTAL
Intervention: MaiStep delivered by teachers (IG2)
Number of subjects: 1654

Group type: COMPARATOR
Intervention: Active Control Group (ACG)
Number of subjects: 1654

Group type: EXPERIMENTAL
Intervention: Healthy subsample (N2)
Number of subjects: 1654

Group type: EXPERIMENTAL
Intervention: Subthreshold eating disorder sample (N3)
Number of subjects: 1654
Study: 29049211

Group type: EXPERIMENTAL
Intervention: Celecoxib 400mg 24 hours preoperative administration (EPEA)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Celecoxib 400mg 1 hour preoperative administration (PEA)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Celecoxib 400mg 4 hours postoperative administration (POA)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Consumption of pethidine
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 206
Study: 25311651

Group type: EXPERIMENTAL
Intervention: Group 1 (20 mg L, 2 mg Z, 0.3 mg MZ)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Group 2 (10 mg L, 2 mg Z, 10 mg MZ)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Group 3 (3 mg L, 2 mg Z, 17 mg MZ)
Number of subjects: 63
Study: 23758974

Group type: EXPERIMENTAL
Intervention: Self-Management Support (SMS) training for practice nurses
Number of subjects: 460

Group type: COMPARATOR
Intervention: Control group (practice nurses without SMS training)
Number of subjects: 460
Study: 21306828

Group type: EXPERIMENTAL
Intervention: Multi Modal Distraction (MMD) Group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Distraction (SD) Group
Number of subjects: 40
Study: 18650802

Group type: EXPERIMENTAL
Intervention: Rotigotine (4 mg/24 h to 24 mg/24 h)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130

Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg)
Number of subjects: 130
Study: 16646724

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 14652861

Group type: EXPERIMENTAL
Intervention: Simple blind variance estimators for sample size recalculation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Permutation test analysis with blind sample size recalculation
Number of subjects: 0
Study: 10941718

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 micrograms of selenomethionine daily)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 23
Study: 9403482

Group type: EXPERIMENTAL
Intervention: Unilateral cerebellar lesions
Number of subjects: 10

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 10
Study: 8473421

Group type: EXPERIMENTAL
Intervention: Modified swim-up sperm preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percoll sperm preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with no sperm preparation
Number of subjects: 0
Study: 31752762

Group type: EXPERIMENTAL
Intervention: Path-oriented Psychological Self-help Intervention (P-oPSI) led by nurses for 1 month
Number of subjects: 76

Group type: COMPARATOR
Intervention: Mental health lecture (wait list control group)
Number of subjects: 76
Study: 29232308

Group type: EXPERIMENTAL
Intervention: Backward Walking Training (BWT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standing Balance Training (SBT)
Number of subjects: 18
Study: 27055853

Group type: EXPERIMENTAL
Intervention: Sequential learning (SEQ)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Simultaneous learning (SIM)
Number of subjects: 53
Study: 24749847

Group type: EXPERIMENTAL
Intervention: Icatibant (30 mg subcutaneously)
Number of subjects: 72